CAPTRUST Financial Advisors
TBIO

CAPTRUST Financial Advisors’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-111
Closed -$4K – 4254
2022
Q2 		$4K Sell
111
-4
-3% -$276 ﹤0.01% 4233
2022
Q1 		$11K Buy
115
+83
+259% +$12.6K ﹤0.01% 3761
2021
Q4 		$6K Buy
+32
New +$4.98K ﹤0.01% 4016

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CAPTRUST Financial Advisors's TBIO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2022, closing a stake of 111 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in TBIO in Q4 2021 and held it in 3 quarters. The position peaked at $11K in Q1 2022. 32 funds tracked by Wall St. Rank hold TBIO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 111 Telesis Bio, Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in Telesis Bio, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Telesis Bio, Inc. Common Stock position peaked at $11K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.